W Mark Saltzman

USPTO Granted Patents = 20 (Patent Applications = 29)

EPO Patents = 1 (Patent Applications = 10)

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 77(Granted Patents)

Location History:

Baltimore, MD (US) (2001)
Ithaca, NY (US) (2001)
New Haven, CT (US) (2014 - 2024)

Company Filing History:

Cornell Research Foundation Inc.

patents

4. 1 out of 1,123

Carnegie Mellon University

Family Health International

patents

7. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2001-2025

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12268774 - Compositions and methods for in utero delivery (2025-04-08),

2. 12233140 - Hyperbranched polyglycerol-coated particles and methods of making and using thereof (2025-02-25),

3. 12162953 - Enhanced targeting platform (2024-12-10),

4. 12030985 - Poly(amine-co-ester) polymers and polyplexes with modified end groups and methods of use thereof (2024-07-09),

5. 11826438 - Hyperbranched polyglycerol-coated particles and methods of making and using thereof (2023-11-28),

6. 11814464 - Poly(amine-co-ester) polymers and polyplexes with modified end groups and methods of use thereof (2023-11-14),

7. 11766400 - Biodegradable contraceptive implants (2023-09-26),

8. 11136597 - Compositions for enhancing targeted gene editing and methods of use thereof (2021-10-05),

9. 10765638 - Particle formulation with polycation complex (2020-09-08),

10. 10682422 - Formulations for targeted release of agents under low pH conditions and methods of use thereof (2020-06-16),

11. 10465042 - Poly(amine-co-ester) nanoparticles and methods of use thereof (2019-11-05),

12. 9895451 - Formulations for targeted release of agents to low pH tissue environments or cellular compartments and methods of use thereof (2018-02-20),

13. 9844585 - Convection enhanced delivery apparatus, method, and application (2017-12-19),

14. 9822364 - Compositions and methods for controlled delivery of inhibitory ribonucleic acids (2017-11-21),

15. 9567430 - Enzymatic synthesis of poly(amine-co-esters) and methods of use thereof for gene delivery (2017-02-14),

Title: W Mark Saltzman: Innovator in Biomedical Engineering

Introduction

W Mark Saltzman is an esteemed inventor and researcher based in New Haven, CT. He holds an impressive portfolio of 19 patents, showcasing his significant contributions to the fields of biomedical engineering and drug delivery systems. His work is pioneering, particularly in maternal-fetal medicine and the design of advanced drug delivery vehicles.

Latest Patents

Among his recent innovations is a patent for "Compositions and methods for in utero delivery," which outlines methods for administering active agents intravenously to pregnant mothers via the vitelline vein, umbilical vein, or directly into the amniotic cavity. This invention aims to correct structural defects of neural tissue using fibroblast growth factor.

Another notable patent is for "Hyperbranched polyglycerol-coated particles and methods of making and using thereof." This patent describes core-shell particles designed to enhance drug delivery by resisting non-specific protein absorption. The hyperbranched polyglycerol (HPG) coating can be modified to attach particles to various tissues and cells, improving therapeutic efficacy.

Career Highlights

Saltzman's career spans key roles at prestigious institutions such as Yale University and Cornell University. His contributions in academia are instrumental in advancing our understanding of drug delivery mechanisms and improving patient outcomes in healthcare.

Collaborations

Throughout his career, W Mark Saltzman has collaborated with notable researchers, including Zhaozhong Jiang and Jiangbing Zhou. These collaborations have fostered innovative research and development, pushing the boundaries of biomedical technology.

Conclusion

W Mark Saltzman's contributions to the field of biomedical engineering demonstrate his commitment to innovation and improving healthcare solutions. His patents represent significant advancements that pave the way for future research and applications in drug delivery and maternal-fetal medicine.

This text is generated by artificial intelligence and may not be accurate.